Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Last modified by Nathalie Bonnefoy
Group name EquipeNB
Item Type Journal Article
Title Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737
Creator Mathieu et al.
Author A. L. Mathieu
Author O. Sperandio
Author V. Pottiez
Author S. Balzarin
Author A. Herledan
Author J. O. Elkaim
Author M. L. Fogeron
Author C. Piveteau
Author S. Dassonneville
Author B. Deprez
Author B. O. Villoutreix
Author N. Bonnefoy
Author F. Leroux
Abstract One approach currently being developed in anticancer drug discovery is to search for small compounds capable of occupying and blocking the hydrophobic pocket of anti-apoptotic Bcl-2 family members necessary for interacting with pro-apoptotic proteins. Such an approach led to the discovery of several compounds, such as ABT-737 (which interacts with Bcl-2, Bcl-xl, and Bcl-w) or the latest one, ABT-199, that selectively targets Bcl-2 protein. The efficacy of those compounds is, however, limited by the expression of two other anti-apoptotic Bcl-2 members, Mcl-1 and Bfl-1. Based on the role of Bfl-1 in cancer, especially in chemoresistance associated with its overexpression in B-cell malignancies, we searched for modulators of protein-protein interaction through a high-throughput screening of a designed chemical library with relaxed drug-like properties to identify small molecules targeting Bfl-1 anti-apoptotic protein. We found two compounds that display electrophilic functions, interact with Bfl-1, inhibit Bfl-1 protective activity, and promote cell death of malignant B cells. Of particular interest, we observed a synergistic effect of those compounds with ABT-737 in Bfl-1 overexpressing lymphoma cell lines. Our results provide the basis for the development of Bfl-1 specific antagonists for antitumor therapies.
Publication J Biomol Screen
Volume 19
Pages 1035-1046
Date May 8 2014
Journal Abbr Journal of biomolecular screening
DOI 10.1177/1087057114534070
ISSN 1552-454X (Electronic) 1087-0571 (Linking)
Tags first-last-corresponding, original
Date Added 2018/11/14 - 12:04:32
Date Modified 2019/05/28 - 21:25:47
Notes and Attachments (Note)
(Note)
24809353 (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés